Skip to main content
U.S. flag

An official website of the United States government

Translational Capabilities: Seamless phase I to phase II transition (Milestone 4.Y)

Evaluate and update current trial funding models to ensure the ability to test novel first-in-class therapeutics in the context of the full range of expenses and time frames required for robust evaluation and sharing.

Success Criteria

  • Create a research program that enables academic institutions and small biopharma companies developing first-in-class AD/ADRD therapeutics to conduct first in human trials and seamlessly transition to early-stage clinical trials in the intended patient population.

Summary of Key Accomplishments

This milestone has yet to be initiated. Accomplishments are forthcoming.

This information is current as of July 2022.

Research Implementation Area
Translational Tools, Infrastructure, and Capabilities
To Be Initiated

Relevant Recommendations

An official website of the National Institutes of Health